Is semaglutide a type of GLP-1, and how does it aid in weight loss
As stated in Lillys press release, Discontinuation rates due to adverse events were 12.2% and 18.2% with retatrutide 9 mg and 12 mg, respectively, compared to 4.0% with placebo
There is no evidence to suggest optimal duration of fasting for patients, so until we have adequate evidence, we will continue with current ASA fasting guidelines
The FTC Takes a ShOt at Telehealth Program for Allegedly Deceptive Pricing, Consumer Reviews, and Weight Loss Claims In an enforcement action akin to an advertising law issue spotting exam, the FTC announced this week a settlement with a telemedicine company and its principals for allegedly using misleading pricing claims that failed to disclose fees and a program term commitment, deceptive reviews and testimonials, and unsubstantiated weight loss claims
Doctors deal with insurance barriers constantly, and most appreciate patients who ask directly rather than silently abandoning treatment when they see the price
Furthermore, in signaling studies that used cell lines with recombinantly expressed human GIPR or GLP-1R, tirzepatide stimulated cyclic adenosine monophosphate (cAMP) accumulation by either receptor with potency similar to that of native GIP and approximately 13-fold weaker than that of native GLP-1 [1]